FDA Inspection 1095930 — Lotus Pharmaceutical Co., Ltd.
The FDA completed an inspection of Lotus Pharmaceutical Co., Ltd. on May 31, 2019 in Nan Tou Xian. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- May 31, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Nan Tou Xian (Taiwan)